Showing results (1761-1770 of 1,932) with videos related to

Sort By:
Pageof 194
RMD Open|November 21, 2024
Impact of autoantibody status on stratifying the risk of organ involvement and mortality in SSc: experience from a multicentre French cohort of 1605 patientsKevin Didier, Vincent Sobanski, Ailsa Robbins, et al.
RMD Open|November 24, 2024
Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with familial Mediterranean feverInès Elhani, Stefan Backes, Tilmann Kallinich, et al.
RMD Open|November 28, 2024
Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosisRucsandra Dobrota, Alexandru Garaiman, Kim Fligelstone, et al.
RMD Open|March 18, 2025
Infliximab use and cervical spine deformity in patients with rheumatoid arthritisAnna Baukje Lebouille-Veldman, Tom W J Huizinga, Rania A Mekary, et al.
RMD Open|October 28, 2024
Value of the central sensitisation inventory in patients with axial spondyloarthritisYvonne Maria van der Kraan, Davy Paap, Hans Timmerman, et al.
RMD Open|October 22, 2024
Digital biomarkers for psoriatic arthritis: a qualitative focus group study on patient-perceived opportunities and barriersPatty de Groot, Wendy Wagenaar, Jasper Foolen, et al.
RMD Open|October 18, 2024
Combining patient-reported outcome measures to screen for active disease in rheumatoid arthritis and psoriatic arthritisAgnes E M Looijen, Selinde V J Snoeck Henkemans, Annette H M van der Helm-van Mil, et al.
RMD Open|October 18, 2024
Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis, including 8 weeks of switching data from reference tocilizumab to CT-P47Josef S Smolen, Jakub Trefler, Artur Racewicz, et al.
RMD Open|September 6, 2024
Inflammatory biomarkers predicting long-term remission and active disease in juvenile idiopathic arthritis: a population-based study of the Nordic JIA cohortMia Glerup, Christoph Kessel, Dirk Foell, et al.
RMD Open|August 9, 2024
Diagnostic accuracy of serum biomarkers to identify giant cell arteritis in patients with polymyalgia rheumaticaAndré Ramon, Hélène Greigert, Karine Goueslard, et al.
Pageof 194